Active in Major League Soccer
Career
No transfer history
Archetypes earned from what we've seen this season.
Player Season Cards
Jon Bell's season performance cards
Bronze
SQUAD PLAYER
23 Appearances
23 Appearances
1320 Minutes Played
6.3 Avg Rating
Jon Bell Traits
Percentile rankings show how a player compares to others. 90% means they rank higher than 90% of comparable players.
vs Defenders
Height 28%
Weight 40%
Experience 68%
vs Major League Soccer
Height 40%
Weight 49%
Experience 72%
Player DNA
Five dimensions that show what kind of player they are
Dribbling 64
Shooting 77
Defense 59
Workrate 23
Passing 49
Key Strength 77 Shooting
Area to Watch 23 Workrate
Match Stats
Recent appearances across all competitions
Could not load matches. Please try again.
| Date | Fixture | FM Score |
|---|---|---|
| Oct 25, 2026 | Sporting Kansas City vs Austin | 36 |
| Oct 29, 2026 | Austin vs Real Salt Lake | 36 |
| Oct 31, 2026 | Los Angeles Galaxy vs Austin | 37 |
| Nov 08, 2026 | Austin vs Portland Timbers | 33 |
Player Market Value
Track Jon Bell's transfer value changes and career value history
Current Value €300K
Peak Value €400K (Q3'21)
€400K €200K €0
Q2'21 Q3'21 Q4'21 Q3'22 Q4'22 Q3'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25
Jonathan Bell has established his role as Austin's Silver-tier Sniper. Arriving in Texas after a career spanning multiple franchises across the country, he is building a formidable reputation as a forward threat while eagerly hunting for the first major trophy of his professional career.
His body of work this season is still emerging, but his impact is undeniable across 315 minutes on the pitch. Making seven appearances, he offers a fascinating hybrid profile that blends defensive toughness with lethal finishing. Bagging two goals in his latest stretch of matches, his form is firmly on an upward trajectory. A stellar Shooting capacity serves as the foundation of his game, proving he only needs a fraction of space to test the goalkeeper and punish the opposition.
The broader market pegs his value at a stable €0M, positioning him as an absolute bargain. The metrics make it clear that his tangible output and clinical edge far outweigh any modest financial expectations.